PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinomaXiaochao Tan, Jonathan M. Kurie, Edward A. Pham et al.|Science Translational Medicine|2020Cited by 68
Allosteric SHP2 inhibitors suppress lung cancer cell migration by inhibiting non-canonical activation of EphA2 via the ERK-RSK signaling pathwayKhanh Cong Nguyen, Hiroaki Sakurai|Scientific Reports|2025Cited by 1